New York, NY -- (SBWIRE) -- 03/20/2013 -- Obagi Medical Products, Inc. (NASDAQ:OMPI) a specialty pharmaceutical company that develops, markets, and sells topical aesthetic and therapeutic prescription skin care systems is currently up (+27.94%) on 8,809,184 shares traded after Valeant Pharmaceuticals International Inc said it would buy Obagi Medical Products Inc for about $344 million to boost its dermatology business. Obagi Medical Products, Inc. (NASDAQ: OMPI) are currently up (+84.21%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Obagi Medical Products Inc. (OMPI)
Gevo, Inc. (NASDAQ:GEVO) shares climbed 16.50 percent to $2.40 in post-market trading. The company announced that it has hired Dr. Stephen P. Toon as its Executive Vice President of Operations and Process Development. In his new role at Gevo, Dr. Toon will have overall responsibility for Gevo's Luverne, Minn. facility from startup through to commercial operation.
Click Here to find out what other Investors are saying about Gevo, Inc. (NASDAQ:GEVO)
Cobalt Internatio (NYSE:CIE) reported EPS of -0.702. For the Current Fiscal year, the company is expected to report EPS of -0.61. For the Next Quarter and Next Year, the company is expected to report EPS of -0.15 and -0.53 respectively. At Current Market Price, CIE is in the distance of +13.10% from its 50-day Moving Average price of $24.9606 and +18.96% from its 200-day Moving Average price of $23.7303.
Are these stocks a buy or sell? Let us help you decide, Check here
Williams-Sonoma, Inc. (NYSE:WSM) posted a 9% jump in its fourth-quarter net income surpassing market expectation at West Elm brand.Shares fell by 34 cents or 0.75% to close at $45.21 on Tuesday and in the pre-market session it took a surge by $2.29 or 5.07% to $47.50 following the news of appraisal in its quarterly dividend by 41%.For the quarter ended the company earned $133.7 million, or $1.34 per share compared to net income of $122.6 million, or $1.17 per share, the prior year.
Total revenue was up by 11% to $1.41 billion.FactSet analysts were predicting earnings of $1.29 per share on revenue of $1.4 billion.Dividends were raised to 31 cents payable May 24 to shareholders of record April 26. Further the company plans to repurchase $750 million of its stock over the next three years.
Williams-Sonoma expects to earn $2.65 to $2.75 per share for the year on revenue between $4.20 billion and $4.28 billion.Analysts expect earnings of $2.82 per share on revenue of $4.23 billion.For the first quarter it forecasts earnings between 33 and 36 cents per share on revenue between $850 million and $870 million. Analyst forecasts earnings of 39 cents per share on revenue of $866.6 million.
Should Investors Buy WSM Now? Free Sign Up Here For WSM Analyst Report
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)